PharmacyCodes



Cefadroxil Micronised Powder en es it fr

Categoria

Cefadroxil Micronised Powder Marchi, Cefadroxil Micronised Powder Analoghi

Cefadroxil Micronised Powder Marchi miscela

  • None

    • Cefadroxil Micronised Powder Formula chimica

    C16H17N3O5S

    Cefadroxil Micronised Powder RX link

    http://www.rxlist.com/cgi/generic/cefadrox.htm

    Cefadroxil Micronised Powder FDA foglio

    Cefadroxil Micronised Powder DMS (foglio di materiale di sicurezza)

    Cefadroxil Micronised Powder Sintesi di riferimento

    LB Crast, Jr., US Pat. 3,489,752 (1969)

    Cefadroxil Micronised Powder Peso molecolare

    363.389 g/mol

    Cefadroxil Micronised Powder Temperatura di fusione

    197oC

    Cefadroxil Micronised Powder H2O Solubilita

    1110 mg / L

    Cefadroxil Micronised Powder Stato

    Solid

    Cefadroxil Micronised Powder LogP

    -0.355

    Cefadroxil Micronised Powder Forme di dosaggio

    Capsula; Tablet; liquido orale

    Cefadroxil Micronised Powder Indicazione

    Per il trattamento delle seguenti infezioni (cute, UTI, ORL) derivante: S. pneumoniae, H. influenzae, stafilococchi, S. pyogenes (gruppo A beta-emolitico di streptococchi), E. coli, P. mirabilis, Klebsiella sp, stafilococchi coagulasi-negativi e lo Streptococcus pyogenes

    Cefadroxil Micronised Powder Farmacologia

    Cefadroxil, una prima generazione di antibiotici cefalosporine, è usato per trattare infezioni del tratto urinario, infezioni della struttura della pelle e della pelle, faringite e tonsillite.

    Cefadroxil Micronised Powder Assorbimento

    Cefadroxil è ben assorbito a somministrazione orale; cibo non interferisce con l'assorbimento.

    Cefadroxil Micronised Powder Tossicita

    Nausea, vomito, diarrea, eruzioni cutanee allergiche si possono verificare

    Cefadroxil Micronised Powder Informazioni paziente

    Patients should be counseled that intibacterial drugs including DURICEF should only be used to treat bacterial infections. They do not treat viral infections (eg. the common cold). When DURICEF is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelyhood that bacteria will develop resistance and will not be treatable by DURICEF or other antibacterial drugs in the future.

    Cefadroxil Micronised Powder Atto interessato organismi

    Batteri enterici e altri eubatteri